logo
[breadcrumb_custom]

Tag: MCRB Stock

AMZN
News

MCRB’s Stock Journey: What Investors Need to Know About Seres Therapeutics Inc’s Performance

Seres Therapeutics Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $6.87 on 04/18/23, and the lowest price during that time was $0.61, recorded on 04/16/24. 52-week price history of MCRB Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Seres Therapeutics Inc’s current trading price is -90.74% away from its 52-week high, while its distance from the 52-week low is 4.04%. The stock’s price range for this period has remained between $0.61 and $6.87.

PNC Stock
News

Seres Therapeutics Inc’s: Contrasting Stock Performances in a Volatile Market

The market performance of Seres Therapeutics Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $6.87 on 04/18/23, with the lowest value for the same timeframe being $0.71, recorded on 04/09/24. 52-week price history of MCRB Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Seres Therapeutics Inc’s current trading price is -89.74% away from its 52-week high, while its distance from the 52-week low is -0.77%. The stock’s price range for this period has

Industry

MCRB’s Financial Health: Exploring Seres Therapeutics Inc’s Debt-to-Equity Ratio of 1.79

Seres Therapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $6.87 on 04/18/23, with the lowest value being $0.73 on 03/15/24. 52-week price history of MCRB Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Seres Therapeutics Inc’s current trading price is -89.26% away from its 52-week high, while its distance from the 52-week low is 0.75%. The stock’s price range for this period has remained between $0.73 and $6.87. The Healthcare

OPEN Stock
Stock

Seres Therapeutics Inc (MCRB) Stock: A Year of Highs and Lows

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Seres Therapeutics Inc’s current trading price is -88.26% away from its 52-week high, while its distance from the 52-week low is 10.10%. The stock’s price range for this period has been between $0.73 and $6.87 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 4.3 million for the day, a number notably lower than the average daily volume of 4.79 million over the last three months. Seres Therapeutics Inc saw a rather unpredictable

Stock

Seres Therapeutics Inc (MCRB) Stock: 52-Week Performance Insights and Trading Volume

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Seres Therapeutics Inc’s current trading price is -87.48% away from its 52-week high, while its distance from the 52-week low is -5.49%. The stock’s price range for this period has been between $0.91 and $6.87 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 8.58 million for the day, a number notably higher than the average daily volume of 5.02 million over the last three months. In terms of market performance, Seres Therapeutics

PNC Stock
Stock

MCRB’s Market Fluctuations: Is Now the Right Time to Invest?

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -21.43%.However, over the last six months, we can see a stronger performance of -69.70%. Over the last 30 days, the price of MCRB has leaped by 0.00%. And in the last five days, it has fallen by -3.51%. Seres Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $6.87 on 04/18/23 and the lowest value